Table 1.
The summary of CMAP amplitude data in control and MCAO rats (mean ± SD)
| Time after MCAO | Control | |||
|---|---|---|---|---|
| Left | Right | t | P | |
| 0 day (n = 9) | 62.4 ± 10.0 | 61.4 ± 10.2 | 0.406 | 0.695 |
| 24 hours (n = 6) | 67.6 ± 16.5 | 57.5 ± 13.9 | 1.746 | 0.141 |
| 7 days (n = 6) | 61.2 ± 8.5 | 61.3 ± 14.5 | −0.035 | 0.973 |
| 14 days (n = 3) | 61.7 ± 11.5 | 60.8 ± 9.1 | 0.358 | 0.755 |
| Time after MCAO | MCAO | |||
| Left | Right | t | P | |
| 0 day (n = 30) | 61.9 ± 10.6 | 62.2 ± 7.7 | −0.160 | 0.874 |
| 24 hours (n = 30) | 61.9 ± 10.4 | 66.6 ± 8.9 | −2.249 | 0.032 |
| 7 days (n = 20) | 60.9 ± 8.4 | 67.3 ± 9.6 | −3.382 | 0.003 |
| 14 days (n = 10) | 61.5 ± 12.7 | 63.0 ± 10.7 | −0.866* | 0.386* |
*Wilcoxon test. SD: Standard deviation; CMAP: Compound muscle action potential; MCAO: Middle cerebral artery occlusion.